Management of Atrial Fibrillation in Primary Care

Similar documents
Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)

GRASP-AF- The National Picture. Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012

Review guidance for patients on long-term amiodarone treatment

Initial assessment of patient with AF in primary care DR BRUCE TAYLOR GPwSI Cardiology SCN Merseyside and Cheshire Clinical Lead Primary care

That the Single Commissioning Board supports the project outlined in this report and proceeds as described.

NHS QIS National Measurement of Audit Acute Coronary Syndrome

Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG:

Atrial fibrillation. Understanding NICE guidance

Tackling atrial fibrillation the health economics evidence

Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

requesting information regarding atrial fibrillation in NHS Ashford Clinical Commissioning Group

Review of devices for early AF detection Nadya Hamedi Primary Care cardiovascular pharmacist Health innovation Network

The introduction of dabigatran etexilate (Pradaxa )

Case Study. A Campaign to Raise Awareness of Atrial Fibrillation (AF) in Lancashire. June 2015.

Atrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency

Patient & Primary Care Checklist

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

Atrial fibrillation: current approaches to management

Stroke Prevention & Atrial Fibrillation. Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015

Atrial fibrillation and anticoagulation therapy

Date of Meeting: Ratified Date: 03/06/2009

GOVERNING BODY REPORT

Pharmaceutical Care of People with Atrial Fibrillation. Course information

Update on Palpitations and AF February 28 th 2018

UNLOCK THE ANSWER. The Reveal LINQ TM System lets your physician learn about your heart while you live your life.

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician

Atrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie

Agenda Item No. 8a SERVICE SPECIFICATION. 1. Introduction:

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting

A SIMPLE SOLUTION FOR CARDIAC MONITORING

Commissioning for value focus pack

Economic Impact Evaluation Case Study: AliveCor Kardia Mobile

Atrial fibrillation and flutter in primary care

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Atrial Fibrillation and Anticoagulants

Treating atrial fibrillation using heat energy delivered to the outside of the heart through a thin tube

The case against structured screening for Atrial Fibrillation in General Practice

Optimising detection and stroke prevention strategies in patients with Atrial Fibrillation in West Hampshire

Controversies in Atrial Fibrillation and HF

Atrial fibrillation detection and management. Professor Lis Neubeck Head of Theme Long Term Conditions

Rhona Maclean

Patient & Primary Care Checklist

Optimising detection and stroke prevention strategies in patients with Atrial Fibrillation in West Hampshire

Setting up and running an effective Syncope Service

ADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE

Treatment strategy decision tree

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation

Management strategies for atrial fibrillation Thursday, 20 October :27

A New Approach to Addressing the Heart Failure Challenge in Primary Care within the Western Locality of NEW DEVON CCG

Atrial Fibrillation. Why It s Important. Updated on 2007 / 11 / 23. Microlife Corp ww.microlife.com. Page 1

Atrial Fibrillation & Arrhythmias

Basics of Atrial Fibrillation. By Mini Thannikal NP-BC Mount Sinai St Luke s Hospital New York, NY

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised

1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

WHAT CAN I DO ABOUT ATRIAL FIBRILLATION? Finding answers about atrial fibrillation

Quality Improvement Tool Instruction Guide GRASP-AF

Atrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist

CAA Medical Department

Reading Assignment (p1-91 in Outline ) Objectives What s in an ECG?

Atrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Clinical guideline for the management of atrial fibrillation

15 16 September Seminar W10O. ECG for General Practice

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION

Post MI LVSD Teach and Treat

Summative Assessment Audit Project. Project Number 02

Atrial Flutter Patient Information

Arrhythmias. A/Prof Drew Richardson. The Canberra Hospital May MB BS (Hons) FACEM Grad CertHE MD

Shropshire and Staffordshire Heart and Stroke Network. Atrial Fibrillation Strategy. February 2012

Direct Current Cardioversion (DCCV)

AHSN Business Case User Guide: Improving AF Identification and Optimising Management to Prevent AF-Related Stroke. Version: 13 March 2017

Saudi Heart Failure Guidelines. Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group

Electrocardiogram interpretation and arrhythmia management:

Atrial Fibrillation Detection in the Community and Hospital settings

Document Details. Patient Group Direction

Lipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention)

The Galway Experience

Summary of 2012/13 QOF Changes

Direct Current (DC) Cardioversion

Antony French Consultant Cardiologist & Electrophysiologist

ECG interpretation in primary care- a role for telemedicine?

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

UNDERSTANDING YOUR ECG: A REVIEW

Leeds West CCG Paediatric asthma project. January 2015-January 2017

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

ECGs: Everything a finalist needs to know. Dr Amy Coulden As part of the Simply Finals series

WHY AM I FAINTING? Finding answers about unexplained fainting

Atrial fibrillation: Who should be referred for ablation therapy for atrial fibrillation?. September 12 th, 2015

RESEARCH INTRODUCTION

BIOTRONIK Clinical Studies IMPACT Clinical Study Patient Information. IMPACT Clinical Study: Patient Information Guide

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME

Case scenarios: Patient Group Directions

NHS England Getting Serious About Prevention

Atrial Fibrillation Effect on QualiTy of life (AFEQT) 1 ST M A Y 2012

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Study methodology for screening candidates to athletes risk

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

Patient Resources: Arrhythmias and Congenital Heart Disease

Management of Arrhythmias The General Practitioners role

Transcription:

Cardiac and Stroke Networks in Lancashire & Cumbria Lancaster Morecambe Carnforth and Garstang PBC North Lancashire Teaching PCT Management of Atrial Fibrillation in Primary Care Jeannie Hayhurst, CSNLC Lauren Butler, CSNLC Andrew Gallagher, GPwSI Tom Pickering, PBC Director

Background Fylde Coast Primary Care Guidelines Cardiac Network Primary Care Group Network Clinical Advisory Group Ratified by Clinical Governance of host organisation National Priority Project with NHS Improvement Heart and Stroke Sign up from NHS North Lancashire (PBC) Six participating practices in Lancaster and Morecambe

Issues Diagnosis Uncertainties with ECG diagnosis Difficulties catching PAF Rate or rhythm control Who to anti coagulate Multiple guidelines Worries re older patients Role of echocardiography Poorly defined pathways

Project aims Primary study To promote opportunistic screening in primary care Ensure accurate and timely confirmation of diagnosis Encourage use of evidence based pathways Secondary study Application of telemedicine ECG interpretation Use of mini clinic single lead ECG device

Participants PBC: 13 practices Six practices in Lancaster and Morecambe participated: Smallest 7 161 3 partners Largest 31 306 21 partners Total nearly 92 000 patients A partner from each practice acted as practice lead for the project

Practice visit Project Guide Guidelines Discussed practice prevalence register validation opportunistic screening Confirmation of diagnosis training needs Local anticoagulation service Prescribing trends

The Algorithm

Anticoagulation NICE guideline but age > 75 high risk factor in it s own right

Raising awareness Practices put manual pulse check in relevant templates Reminders on electronic BP machines

Audit Figures were collected at baseline and 12 months after introduction of the guideline Figures were collected by practice pharmacists and practice nurses using QoF data Collected Patient numbers by age Warfarin and aspirin Rate and rhythm controlling treatments

Results: overall prevalence Pre Post Practice Practice population Total number AF register Prevalence % Practice population Total number AF register Prevalence % Relative change % A 10500 189 1.8 10397 199 1.9 +6.33 B 13372 217 1.6 13450 216 1.6 1.03 C 9218 143 1.6 9168 150 1.6 +5.5 D 20059 116 0.6 19882 119 0.6 +3.5 E 31306 573 1.8 32002 619 1.9 +5.7 F 7161 135 1.9 7098 146 2.1 +9.1 Total 91616 1373 1.50 91997 1449 1.58 +5.1 Already exceed national prevalence figures of 1.3% D is the university practice with 12 000+ student population; this would have diluted overall prevalence; prevalence excluding students 1.76% pre, 1.84% post Increase in patients on AF register 76 Absolute increase 0.08%, relative increase of 5.1%

Results: prevalence > 75 years Pre Practice population > 75 years Number on AF register > 75 years Prevalence % > 75 years Post Practice population > 75 years Number on AF register > 75 years Prevalence % > 75 years Relative change % A 942 100 10.6 911 117 12.8 +21.0 B 997 109 10.9 1041 120 11.5 +5.4 C 622 74 11.9 633 83 13.1 +12.8 D 576 69 12.0 568 74 13.0 +8.8 E 3043 325 10.7 3014 352 11.7 +9.3 F 725 84 11.6 715 90 12.6 +8.6 Total 6905 761 11.02 6882 836 12.15 +10.2 Increase in patients on AF register over 75 of 75 Absolute increase 1.13 % relative increase of 10.2%

Prophylaxis Aspirin use reduced slightly from 40.6 to 40.3% Warfarin usage increased from 41.2 to 47.5% Warfarin use in over 75s remained static at 45.9%

Rate and rhythm controlling drugs Digoxin usage dropped from 33.4 to 31.0% Beta blocker usage and RLCCB usage both remained static at 41% and 14% respectively No significant change in rates of prescription of rhythm controlling drugs

Summary of findings Increase in prevalence especially in the over 75s Trend to increased warfarin use though no change in over 75s Trend to reduced use of digoxin

What it didn t tell us How many patients were new presentations and how many were due to register validation/improved coding Although we had good levels of anticoagulation, how many were appropriate For those not on warfarin, were there contraindications If there was any impact on referral to secondary care

GP perception of study Felt to have been very useful Most practices have followed on with further audits We have done a lot on AF as a result of this project, 2x medical student Special Study Modules since Jan 09 have had AF focus I m sure that the majority of us are more switched on about current guidelines for treatment of AF and the patient s are getting a better quality of service. In summary I think it has been very worthwhile. It did involve a lot of work

Telemedicine pilot Practices identified uncertainty over ECG interpretation as an issue Seen as an opportunity to pilot role of telemedicine for interpretation of ECGs in Primary care Assess ease of use and clinical and impact of technology for ECG interpretation and single lead diagnostic monitoring

Project outline Assess ease of use and clinical and personal impact of technology for ECG Interpretation and single lead diagnostic monitoring Assess patient population for clinical requirements for ECG recordings Assess GP competency levels for ECG Interpretation to inform GP s, secondary care and PCTs Share findings and support wider dissemination

Two parts: 12 lead ECG interpretation Use of single lead device

ECG Interpretation ECG taken Passed to GP Audit from completed Indication for ECG: clinical symptoms (73%) long term conditions (21%) referral work up and screening (6%) GP interpretation ECG faxed to Broomwell Result returned to practice Review by GP and collation of results ECGs reviewed by local cardiologist

Results 4 out of the 6 practices participated 193 ECGs analysed Mismatch in 35 out of 193 = 18% 25 different emphasis ectopics, borderline axis deviation, partial RBBB, sinus brady 10 felt to be significant = 5% ST/T changes, long QT, 1 o HB, LVH Changed outcome in 2/193

GP perceptions of the service Significant extra work (but this was a study) On the whole GPs felt this was a quality service but that it was unnecessary to send all ECGs In practice there are only a small number of ECGs where GPs feel they need a specialist opinion Felt this was best provided by local cardiologists (? protected time? Use of non face to face consultation tariff)

Single lead device worn as wristwatch stores up to 5 recordings - advised transmission after each one USB modem to download to PC and transmit to Broomwell report and recording received within 24 hours by email or fax GP is able to view the ECGs

Single lead diagnostic results Only eight patients used the single lead monitoring device, audit data received for 5, included: 55 year old, exercise induced flutter, post stent, used out cycling to confirm this wasn t occurring 60 year old female, history suggestive of ectopics, confirmed sinus rhythm 45 year old female palpitations? SVT. Confirmed SVT but unable to be precise re exact type 55 year old male, known PAF, used in surgery to confirm he was in AF at the time

Summary of single lead device findings The single lead diagnostic device was seen as a very useful tool in investigation of arrhythmias Under utilized but we only had it for a short period Patients liked it and found it easy to use

Next steps Rolling out guideline to all of our PBC practices Introduce CHADS2 as standard decision making tool Encourage practices to use GRASP tool As a result of using the single lead device and a recent audit of 24 hour ECGs, would be useful to review open access investigations in light of newer technologies Possible redesign of arrhythmia service

Atrial Fibrillation algorithm

Any questions?